Latest / The BioHub - by Avetix
Episode 160 - Elizabeth Jeffords - CEO at Iolyx Therapeutics
Today, we’re joined by a leader working at the cutting edgeof immunology and eye disease. Elizabeth Jeffords is the CEO of Iolyx Therapeutics, a clinical-stage biotech company focused on transforming how we treat inflammatory and autoimmune diseases of the eye.
Iolyx sits at the emerging intersection of immunology andophthalmology—what’s often called immuno-ophthalmology. The company is developing targeted therapies designed to treat ocular inflammation right at its source, with the goal of replacing older treatments like steroids and broadimmunosuppressants with more precise…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.